Free Newsletter
New NIH chief faces some big challenges
The new head of the NIH will face some big challenges ahead, reports the Washington Post. Among the biggest hurdles: Reversing a decline in overall federal funding for research, a trend that's lasted for the past five years, and continuing the unwritten rule of preventing the president from influencing research initiatives too much.
You can bet that there will be a big push to gain more money for research. The Post notes that the NIH is handing out $29.5 billion this year, primarily through 50,000 grants to 325,000 scientists. And about 10 percent of its budget goes to support 6,000 staff researchers. Those jobs should count for a lot in this economy, says departing NIH chief Elias Zerhouni (photo).
"We are a knowledge economy, we are not a manufacturing economy," says Zerhouni, who ran the NIH for six years. "NIH provides an enormous opportunity for sustaining economic activity. I am hoping the new administration will focus on this issue."
- read the report in the Washington Post
Related Articles:
Zerhouni's departure from NIH follows controversial tenure
Warning: flat NIH budget threatens 'dead end'
Dwindling NIH funds triggers research "crisis"
Research groups angry as NIH funding stays flat
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: